Cross Country Healthcare Q4 EPS $0.29 Beats $0.27 Estimate, Sales $414.04M Beat $404.42M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cross Country Healthcare (CCRN) reported Q4 earnings of $0.29 per share, surpassing the $0.27 estimate, and sales of $414.04M, exceeding the $404.42M estimate. However, this represents a 73.39% decrease in earnings and a 34.09% decrease in sales from the same period last year.

February 21, 2024 | 11:28 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cross Country Healthcare reported higher than expected Q4 earnings and sales, but with significant decreases from the previous year.
While CCRN exceeded analyst expectations for Q4, the significant year-over-year decline in both earnings and sales may concern investors. The positive earnings surprise could provide short-term stock support, but the substantial decreases highlight potential challenges in the company's performance and sector. The mixed results make the short-term impact neutral as investors weigh the earnings beat against the declines.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100